https://www.selleckchem.com/pr....oducts/tc-s-7009.htm
Eligibility criteria of fertility-sparing management in patients with cervical cancer were tumor size 1 cm, and no parametrium invasion. For patients with endometrial cancer, these included no myometrial and cervical stroma invasion. Both ultrasound and MRI play a key role in characterizing adnexal masses. These modalities provide a useful tool in identifying small ovarian lesions, thus key in the surveillance of patients after fertility sparing surgery. However, efficacy in excluding disease beyond the ovary remains limited. This rev
Curtir
Comentario
Compartilhar
